Inflammatory Responses Unknown Status Phase 4 Trials for Ergocalciferol (DB00153)

Also known as: Inflammatory Response

IndicationStatusPhase
DBCOND0062877 (Inflammatory Responses)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01417923The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal PainTreatment